Palo Verde Hematology-Oncology is categorized under Hematologists in Scottsdale, AZ .
Palo Verde Hematology-Oncology was established in 0, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Hematologists business, which does work in the B2C market, and is classified as a Hematologists, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Kathy Franks, Manager at the company’s single location by writing to 10460 North 92nd St # 402, Scottsdale, Arizona AZ 85258 or by phoning (480) 941-1211. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Palo Verde Hematology-Oncology |
| Contact Person: | Kathy Franks, Manager |
| Address: | 10460 North 92nd St # 402, Scottsdale, Arizona 85258 |
| Phone Number: | (480) 941-1211 |
| Website Address: | pvhomed.com |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hematologists |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
Palo Verde Hematology-Oncology was started in 0 to provide professional Hematologists under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Kathy Franks, Manager for inquiries that concern Palo Verde Hematology-Oncology by calling the company number (480) 941-1211, as your correspondence is most welcome. Additionally, the physical location of the single location of Palo Verde Hematology-Oncology can be found at the coordinates 33.5816,-111.88274 as well as the street address 10460 North 92nd St # 402 in Scottsdale, Arizona 85258.
For its online presence, you may visit Palo Verde Hematology-Oncology’s website at pvhomed.com and engage with its social media outlets through on Twitter and on Facebook.